Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Literature DB >> 19665675

Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Abstract

The heterogeneity of von Willebrand disease reflects the varied roles of von Willebrand factor in coagulation. Significant challenges remain in the detection, classification, and determination of bleeding risk in disorders related to von Willebrand factor. A clearer understanding of the specific disease mechanisms is essential to the development of improved methods for prognosis and management in this and other conditions with abnormalities of the von Willebrand factor system.

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2009 PMID： 19665675 PMCID： PMC7184927 DOI： 10.1016/j.cll.2009.06.005

Source DB: PubMed Journal: Clin Lab Med ISSN： 0272-2712 Impact factor: 1.935

78 in total

1. Effect of von Willebrand factor Y/C1584 on in vivo protein level and function and interaction with ABO blood group.

Authors: James Anthony Davies; Peter William Collins; Lee Sarah Hathaway; Derrick John Bowen
Journal: Blood Date: 2007-04-01 Impact factor: 22.113

2. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.

Authors: Paula D James; Colleen Notley; Carol Hegadorn; Jayne Leggo; Angie Tuttle; Shawn Tinlin; Christine Brown; Chandler Andrews; Andrea Labelle; Yvette Chirinian; Lee O'Brien; Maha Othman; Georges Rivard; Dilys Rapson; Christine Hough; David Lillicrap
Journal: Blood Date: 2007-01-01 Impact factor: 22.113

3. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease.

Authors: An De Vleeschauwer; Katrien Devreese
Journal: Blood Coagul Fibrinolysis Date: 2006-07 Impact factor: 1.276

Review 4. von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis.

Authors: Ida Martinelli
Journal: Semin Hematol Date: 2005-01 Impact factor: 3.851

5. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).

Authors: Anne Goodeve; Jeroen Eikenboom; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jorgen Ingerslev; David Habart; Zdena Vorlova; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Mohammad Hashemi Soteh; Luciano Baronciani; Christer Hallden; Andrea Guilliatt; Will Lester; Ian Peake
Journal: Blood Date: 2006-09-19 Impact factor: 22.113

Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

1. Effect of von Willebrand factor Y/C1584 on in vivo protein level and function and interaction with ABO blood group.

2. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.

3. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease.

Review 4. von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis.

5. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).

6. Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy.

Review 7. Shear stress and von Willebrand factor in health and disease.

Review 8. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.

9. Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues.

10. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race.

1. Clinical measurement of von Willebrand factor by fluorescence correlation spectroscopy.